Multiple Myeloma (MM) is the second most prevalent hematological neoplasia in the United States. It is characterized by infiltration of tumor plasma cells in the bone marrow, synthesis of monoclonal immunoglobulins and tissue damages, such as osteolytic lesions. Despite of the progress achieved in the last decades regarding the frontline treatment for MM, this malignant neoplasia remains incurable. The possible existence of cancer stem-cells of MM (MM-CSC) explains the disease's relapse and resistance to treatments. This way, studies aiming a better characterization and comprehension of MM-CSC, focusing on finding potential therapeutic targets, are essential for developing new medications capable of promoting better survival and quality of life to the individuals affected by this disease. Thus, our intention is to identify and isolate these cancer stem-cells, which might be a potential therapeutic target for the disease.
News published in Agência FAPESP Newsletter about the scholarship: